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Modulation of Haemophilus 
influenzae interaction with 
hydrophobic molecules by the VacJ/
MlaA lipoprotein impacts strongly 
on its interplay with the airways
Ariadna Fernández-Calvet1, Irene Rodríguez-Arce1, Goizeder Almagro1, Javier Moleres1, 
Begoña Euba1,2, Lucía Caballero1, Sara Martí2,3, José Ramos-Vivas4,5, Toby Leigh 
Bartholomew6, Xabier Morales7, Carlos Ortíz-de-Solórzano7,8, José Enrique Yuste2,9,  
José Antonio Bengoechea  6, Raquel Conde-Álvarez10 & Junkal Garmendia1,2
Airway infection by nontypeable Haemophilus influenzae (NTHi) associates to chronic obstructive 
pulmonary disease (COPD) exacerbation and asthma neutrophilic airway inflammation. Lipids are key 
inflammatory mediators in these disease conditions and consequently, NTHi may encounter free fatty 
acids during airway persistence. However, molecular information on the interplay NTHi-free fatty 
acids is limited, and we lack evidence on the importance of such interaction to infection. Maintenance 
of the outer membrane lipid asymmetry may play an essential role in NTHi barrier function and 
interaction with hydrophobic molecules. VacJ/MlaA-MlaBCDEF prevents phospholipid accumulation at 
the bacterial surface, being the only system involved in maintaining membrane asymmetry identified 
in NTHi. We assessed the relationship among the NTHi VacJ/MlaA outer membrane lipoprotein, 
bacterial and exogenous fatty acids, and respiratory infection. The vacJ/mlaA gene inactivation 
increased NTHi fatty acid and phospholipid global content and fatty acyl specific species, which in turn 
increased bacterial susceptibility to hydrophobic antimicrobials, decreased NTHi epithelial infection, 
and increased clearance during pulmonary infection in mice with both normal lung function and 
emphysema, maybe related to their shared lung fatty acid profiles. Altogether, we provide evidence for 
VacJ/MlaA as a key bacterial factor modulating NTHi survival at the human airway upon exposure to 
hydrophobic molecules.
The Gram-negative coccobacillus nontypeable (non-capsulated) Haemophilus influenzae (NTHi) is a common 
commensal in the nasopharynx of healthy humans, but also an opportunistic pathogen causing respiratory 
infections such as acute otitis media, otitis media with effusion, community-acquired pneumonia, conjunctivitis 
and, occasionally, bacteraemia. NTHi colonization is also associated with exacerbations of chronic obstructive 
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pulmonary disease (COPD) and with neutrophilic airway inflammation in asthma patients. Since the introduc-
tion of a vaccine against H. influenzae serotype b in the 1990s, the burden of H. influenzae-related infections has 
been increasingly dominated by nontypeable strains. Thus, understanding the ability of this pathogen to colonize 
and cause infection is an expanding area of study. Current knowledge suggests that NTHi survival in the host is a 
multifaceted process coordinately orchestrated by a whole range of virulence factors1–3.
COPD is a progressive and not fully reversible airflow limitation accompanied by emphysema, fibrosis, neu-
trophil infiltration and mucus hypersecretion4; conversely, asthma is an airway chronic inflammatory condition 
distinguished by abnormal immune responses leading to recurrent cough, wheezing and breathlessness5. Existing 
evidence suggests the involvement of several lipids as key molecular mediators of disease in emphysema, chronic 
bronchitis and asthma6. In fact, arachidonic acid metabolites are key players in COPD and asthma-related air-
way inflammation7, and oleic acid is associated with pulmonary injury, a trademark of acute respiratory distress 
syndrome8,9. Thus, NTHi is likely to encounter and/or interact with free fatty acids during infection of the human 
lower airways. Of note, a bactericidal effect of arachidonic acid has been shown for H. influenzae10; in turn, this 
pathogen should be equipped with mechanisms to preserve barrier function, therefore modulating its interaction 
with free fatty acids.
H. influenzae contains gene homologs to the Escherichia coli fadL and fadD genes, encoding an exogenous 
long-chain fatty transporter and an acyl-CoA synthase/fatty acid-CoA ligase, respectively, but it lacks those 
encoding the enzymes involved in fatty acid degradation via β-oxidation11. As a consequence, NTHi is unlikely 
to use free fatty acids as sole carbon and energy source, but just to synthesize phospholipids. Likewise, H. influ-
enzae contains gene homologs to the fabABDGHIZ and accABCD fatty acid biosynthetic genes, and to the plsB 
and plsC genes, encoding two acyltransferases involved in generation of phosphatidic acid, the precursor to all 
phospholipids, shown to be phosphatidyl ethanolamine (PE) and phosphatidyl glycerol (PG) in H. influenzae11,12.
Phospholipids are part of the inner membrane and the inner leaflet of the outer membrane of Gram negative 
bacteria. The maintenance of the outer membrane lipid asymmetry is critical for its permeability barrier func-
tion13,14. To prevent damage resulting from surface-exposed phospholipids, E. coli has the phospholipase PldA, 
which removes the sn-1 and sn-2 fatty acid side chains from phospholipids and lysophospholipids (EC 3.1.1.32), 
the palmitoyltransferase PagP, cleaving palmitate of a suitable phospholipid to transfer it to lipid A (EC 2.3.1.251), 
and the Mla ABC transport system (maintenance of the lipid asymmetry, vacJ/mlaA-mlaBCDEF system), facil-
itating a retrograde phospholipid transport from the outer- back to the inner membrane15. VacJ/MlaAE. coli is a 
lipoprotein acting in concert with the osmoporin OmpC at the bacterial outer membrane. Moreover, Mla system 
deficiency is suppressed by increased levels of PldA, and compensated by PagP mediated conversion of lipid A 
from the hexa- to hepta-acylated form15,16. H. influenzae contains a Mla pathway homolog, but it lacks PldA and 
PagP homologs. VacJ/MlaA (hereafter VacJ) mediated maintenance of the outer membrane stability is important 
for NTHi serum resistance, by limiting the recognition of surface oligosaccharide epitopes by natural IgM, which 
promotes killing via the classical pathway of complement activation17. This observation may relate to the pro-
posed vacJ gene implication in lung pathogenesis18.
Together, the existing evidence prompted us to hypothesize that VacJ function may also be important to mod-
ulate NTHi interplay with hydrophobic antimicrobials, by maintaining bacterial fatty acid-phospholipid content 
and surface properties, therefore facilitating the human airway infection. To investigate the relationship among 
VacJ, fatty acids and respiratory infection by NTHi, we generated vacJ mutant and chromosome complemented 
strains by employing two genome sequenced strains, NTHi strain 375, hereafter NTHi375, and H. influenzae (Hi) 
RdKW2011,19. We evaluated the effects of this mutation on bacterial growth, morphology, membrane integrity and 
hydrophobicity, fatty acid and phospholipid composition, lipooligosaccharide (LOS) lipid A structure and phos-
phorylcholine (ChoP) decoration, antimicrobial resistance, and on the NTHi-host interplay by using cultured 
airway epithelia and a murine model of respiratory infection with normal lung function or induced emphysema. 
In this study, we demonstrate that inactivation of the vacJ gene increased bacterial fatty acid and phospholipid 
content, lowered NTHi resistance to a whole range of hydrophobic molecules, and resulted in reduced epithelial 
infection and murine lung enhanced bacterial clearance. Together, this work provides compelling evidence for 
VacJ being a key bacterial factor playing an important role in the NTHi-host interplay at the airways.
Results
Generation and characterization of vacJ mutant strains in H. influenzae. Two-hundred and 
ninety eight available nontypeable H. influenzae whole genome sequences were downloaded and used to assess 
the presence of the Mla system through the TBLASTN tool by local BLAST. Gene homologs to those encoding 
the E. coli Mla system were shown to be present in all strains. Similar to E. coli, the vacJ gene and the mlaBCDFE 
operon occupy separate genomic locations (Fig. 1A). NTHi375 and RdKW20 strains were employed to generate 
vacJ mutants (vacJ gene accession numbers NF38_01540 and HI0718, respectively). The vacJ gene is predicted to 
encode a lipoprotein located at the bacterial outer membrane. VacJNTHi375 and VacJRdKW20 present a putative signal 
sequence (MKTKVILTALLSAIALTGC and MKTKTILTALLSAIALTGC, respectively) in amino acids 1–19, and 
a lipobox sequence (Leu-Thr-Gly-Cys) in amino acids 16–19. At the protein level, VacJNTHi375 and VacJRdKW20 
displayed 98.4% identity; VacJNTHi presents homologs in other Gram-negative bacteria20.
NTHi mutants lacking the vacJ gene were selected on sBHI agar. These strains rendered normal size colonies 
(Fig. S1A). ΔvacJ mutants growth in sBHI was comparable to that of their respective isogenic wild type (WT) 
strains (Fig. 1B). Similar bacterial morphology was also observed for WT and mutant strains when assessed by 
transmission electron microscopy (TEM) (Fig. 1E). Deletion of the vacJ gene is known to impair outer mem-
brane stability in several Gram negative bacteria including H. influenzae, leading to increased detergent sensi-
tivity17,21–23. In agreement, in the presence of sodium deoxycholate, both NTHi375 and RdKW20 vacJ mutants 
showed bacterial cell morphology changes, and a sodium deoxycholate dose dependent reduction of viability, 
which could be chromosomally complemented (Figs 1C–E and S1B).
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Figure 1. Characterization of NTHi vacJ mutants. (A) Schematic representation of vacJ and mlaBCDEF 
genome distribution in strains NTHi375 and RdKW20. (B) H. influenzae growth in sBHI is not modified by 
vacJ gene mutation. Bacterial growth is shown for NTHi375 (left) and RdKW20 (right) WT and vacJ mutant 
strains. Growth in sBHI is shown as a mean of OD636 at the indicated time points. Experiments were performed 
in triplicate, in three independent occasions (n = 9). (C–E) Sodium deoxycholate bactericidal effect on 
NTHi depends on VacJ. NTHi WT and ΔvacJ strains grown on chocolate agar were used to generate OD600-
normalized bacterial suspensions for further incubation with sodium deoxycholate. After 20 min, deoxycholate 
dose dependent bactericidal effect was higher on the ΔvacJ mutant than on the WT strains, as measured by 
assessing bacterial growth on sBHI (C,D). In (C), bacterial counts are shown as log10 c.f.u./ml (mean ± SE). For 
both NTHi375 and RdKW20, vacJ mutant viability was lower than WT strain at [deoxycholate] between 1 and 
1.5 mg/ml (*p < 0.0005). Experiments were performed in duplicate and in three independent occasions (n = 6). 
Statistical comparison of the means was carried out using one-way ANOVA (Dunnett’s multiple comparisons 
test). (E) Inactivation of the vacJ gene altered bacterial morphology in the presence of deoxycholate, observed 
by TEM. NTHi375 WT (left) and ΔvacJ mutant (right) strains are shown. Upper panels: examples of 
transmission electron micrographs of negatively stained bacteria grown for 12 h on chocolate agar at 37 °C 
with 5% CO2. Original magnification ×60.000. Bars: 0.25 µm. Lower panels: examples of transmission electron 
micrographs of negatively stained bacteria grown as indicated above, washed in PBS and incubated with 
0.5 mg/ml deoxycholate for 20 min. Original magnification ×50.000; Bars: 0.5 µm. (F) VacJ modulates NTHi 
ChoP level. WT and ΔvacJ strains were exponentially grown in sBHI, incubated with anti-ChoP antibody, and 
antibody binding was analysed by flow cytometry. ChoP detection was higher in ΔvacJ than in the WT strains 
(mean ± SE, *p < 0.005). Experiments were performed in quadruplicate and in three independent occasions 
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Moreover, it has been previously shown that mutation of the vacJ gene in H. influenzae strain R2866 increases 
the amount of ChoP on the LOS molecule17. NTHi375ΔvacJ and RdKW20ΔvacJ strains also showed signifi-
cantly higher ChoP level than their respective WT strains (p < 0.005) when measured by flow cytometry with the 
murine monoclonal antibody TEPC-15, and this phenotype could be restored to WT levels in the ΔvacJ com-
plemented strains (Fig. 1F). We asked if such ChoP increase could be related to the lic1A gene phase variation or 
to changes in lic1ABCD gene expression. The lic1A gene was sequenced in WT and vacJ mutant strains, showing 
the same number of repeats of the tetranucleotide (5′CAAT)n (Fig. S1C); similarly, lic1A gene expression was 
comparable between WT and vacJ mutant strains (Fig. 1G).
In summary, disruption of the vacJ gene did not modify NTHi morphology and growth under the conditions 
tested; differently, it affected NTHi outer membrane stability and increased bacterial surface decoration with 
ChoP, independently of the lic1A gene expression or phase variation.
Disruption of the vacJ gene modifies NTHi fatty acid content. The content of NTHi surface phos-
pholipids has been shown to increase upon vacJ gene mutation17. Such modification may relate to variations 
in bacterial fatty acid composition, in terms of fatty acyl residues type and/or amount. Based on this notion, 
bacterial total fatty acid methyl ester composition was analysed by gas chromatography and mass spectrometry 
(GC-MS), showing increased content of total fatty acids in vacJ mutant compared to WT strains (for NTHi375 
and RdKW20, p < 0.005) (Fig. S2A). The same type of fatty acyl residues, consisting of straight saturated C14:0 
(myristic and 3-hydroxymyristic), C16:0 (palmitic), C18:0 (stearic) and unsaturated C16:1 (palmitoleic) acid 
was observed in all tested strains. ΔvacJ mutants displayed increased content of palmitic (for NTHi375 and 
RdKW20, p < 0.0005) and palmitoleic acid (for NTHi375 and RdKW20, p < 0.0005), compared to their WT 
isogenic strains. The content of palmitoleic shown by vacJ complemented strains was similar to that of the WT 
strains; this was not the case for palmitic acid content (for NTHi375 and RdKW20, p < 0.0005). No significant 
differences were observed for myristic, 3-hydroxymyristic (C14:0-3-OH) and stearic acid levels between WT and 
vacJ mutant strains (Fig. 2A).
The H. influenzae lipid A disaccharide backbone is known to be composed of two 2-amino-2-deoxyglucose 
residues linked by a β-(1–6) glycosidic linkage and phosphorylated at positions 1 and 4′. The C2/C2′ and C3/C3′ 
positions are substituted by amide-linked and ester-linked myristic acid, respectively; fatty acid chains on C2′ 
and C3′ are further esterified by 14:0, and fatty acid chains on C2 and C3 are 3-hydroxymyristic acid24. We next 
assessed WT and vacJ mutant strains lipid A species by MALDI-TOF mass spectrometry. All strains showed a 
major lipid A species corresponding to the hexa-acylated form (m/z 1,824)24,25. The ion peak corresponding to 
m/z 1,744, likely to represent the monophosphorylated hexa-acylated lipid A, showed lower intensity in vacJ 
mutant than in WT strains; no differences among strains were observed for the ion peak with m/z 1,388, which 
may represent a tetra-acyl lipid A24,25 (Fig. 2B).
As previously stated12, thin layer chromatography (TLC) analysis showed that H. influenzae WT and vacJ 
mutant phospholipids are phosphatidyl ethanolamine (PE) and phosphatidyl glycerol (PG) (Fig. S2B). PG showed 
C16:0 and C18:0 in all tested strains, and C16:0 was shown to be the most abundant one. A higher PG fatty acid 
content was observed, being significant for C16:0 in both ΔvacJ mutants (for NTHi375, p < 0.05; for RdKW20, 
p < 0.005), and for C18:0 in RdKW20ΔvacJ (p < 0.05) (Fig. 2C, left panel). PE displayed C14:0, C16:0, C16:1 
and C18:0, being also C16:0 the most abundant. ΔvacJ mutants showed increased palmitic acid (for NTHi375, 
p < 0.05; for RdKW20, p < 0.0001) compared to their isogeneic WT strains (Fig. 2C, right panel).
The observed increased fatty acid content led us to assess bacterial surface hydrophobicity. Although we did 
not observe striking differences between isogenic WT and ΔvacJ strains, a slight but consistent tendency to 
increased bacterial surface hydrophobicity in the absence of the vacJ gene could be seen (Fig. S2C).
Together, our results show increased amount of total fatty acids and identify specific fatty acyl residues raised 
in NTHi vacJ mutant strains, i.e. palmitic and palmitoleic acid. Such fatty acid increase may relate to changes in 
bacterial phospholipid composition, without having a gross influence on lipid A acylation patterns, altogether 
supporting the notion that NTHi vacJ mutants may have increased surface hydrophobicity compared to their 
isogenic parental strains.
Inactivation of the vacJ gene lowers NTHi resistance to hydrophobic antibiotics. The obser-
vations above prompted us to speculate that changes in bacterial surface hydrophobicity may modify antibiotic 
susceptibility. We tested bacterial susceptibility to 12 hydrophilic antibiotics, showing no differences between 
WT and mutant strains (Table S1). In contrast, NTHi375 and RdKW20 vacJ mutants were more susceptible to the 
hydrophobic antibiotics erythromycin, rifampicin and azithromycin (Table 1). In this case, phenotypic restoration 
could not be performed because the complemented strains are resistant to erythromycin (see Methods section). 
Together, bacterial changes associated to vacJ mutation were found to contribute increasing NTHi susceptibility 
to hydrophobic antibiotics.
The vacJ gene mutation increases H. influenzae susceptibility to ionic antimicrobials. Changes 
in resistance to hydrophobic antibiotics may also be extended to other antimicrobials with hydrophobic regions. 
Polymyxins consist of a cyclic heptapeptide ring with a tripeptide side chain covalently bound to a fatty acid via 
(n = 12). Statistical comparison of the means with one-way ANOVA (Dunnett’s multiple comparisons test) was 
carried out. (G) Comparable expression of the lic1A gene between WT and vacJ mutant strains, exponentially 
grown in sBHI. Experiments were performed in duplicate and in three times (n = 6). Statistical comparison of 
the means using two-tail t-test was performed.
www.nature.com/scientificreports/
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an acyl group. The polycationic peptide ring interacts with the lipid A, and the fatty acid portion interacts with 
the hydrophobic region of the outer membrane, driving loss of membrane integrity and bacterial cell death26,27. 
Following this notion, we next tested NTHi WT and mutant strains resistance to the antimicrobial peptide poly-
myxin E (PxE, also known as colistin). We observed increased PxE susceptibility for both ΔvacJ strains (MICPxE 
of 0.032 mg/l), compared to that of the WT strains (for NTHi375, MICPxE of 0.094 mg/l; for RdKW20, MICPxE of 
0.064 mg/l) (Table 1).
Disruption of the vacJ gene in H. influenzae increases bacterial susceptibility to free fatty 
acids. Free fatty acids are considered as natural detergents; in fact, a bactericidal effect on H. influenzae 
has been described for arachidonic acid (C20:4)10. The results above led us to speculate that lacking the vacJ 
gene may further increase bacterial susceptibility to fatty acids. Based on this notion, we assessed the result of 
Figure 2. Determination of NTHi fatty acid composition by GC-MS. (A) Total fatty acid composition, as 
methyl esters (means ± SE). Bacteria grown on chocolate agar were used to extract fatty acids, by following 
saponification, methylation, extraction and washing steps. vacJ mutants showed increased amounts of C16:0 
and C16:1 compared to the WT strains (for NTHi375 and RdKW20, *p < 0.0005). ΔvacJ complemented strains 
showed amounts of C16:1 comparable to those of the WT strains; increased amounts of C16:0 were maintained 
in the ΔvacJ complemented strains (for NTHi375 and RdKW20, *p < 0.0005). Quantifications were performed 
in duplicate and in three independent occasions (n = 6). (B) Determination of NTHi lipid A species by MALDI-
TOF for NTHi375 (left) and RdKW20 (right) WT and vacJ mutant strains. (C) TLC band corresponding to PE 
and PG phospholipids were scraped to analyse their fatty acid composition. Assays were performed in duplicate 
and in three independent occasions (n = 6) (means ± SE are shown). PG C16:0 content was higher in the vacJ 
than in the WT strains (for NTHi375, *p < 0.05; for RdKW20, **p < 0.005). PG C18:0 content was higher in the 
vacJ than in the WT strains (for RdKW20, *p < 0.05). PE C16:0 content was also higher in the vacJ than in the 
WT strains (for NTHi375, *p < 0.05; for RdKW20, ***p < 0.0001). Statistical comparisons of the means were 
carried out with two-way ANOVA (Sidak’s multiple comparisons test).
www.nature.com/scientificreports/
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NTHi interaction with exogenous fatty acids. To do so, bacterial growth in a defined medium free of fatty acids 
(MM-FFA), where a carbon source can be added ad hoc, was first optimized. Medium composition and NTHi 
bacterial growth when using glucose 20 mM as carbon source are shown in Table S2 and Fig. 3A, respectively. 
NTHi is unlikely to degrade exogenous long-chain fatty acids due to the absence of β-oxidation, therefore exclud-
ing the use of such molecules as sole carbon and energy source by this pathogen. As expected, bacterial growth 
in MM-FFA could not be recorded when using either arachidonic acid or vehicle solution as carbon source; vacJ 
mutants showed similar behaviour to their respective WT strains (Fig. 3A). To further determine NTHi viability 
in the presence of free fatty acids, NTHi WT and vacJ mutant strains were inoculated in MM-FFA in the pres-
ence of arachidonic (C20:4) or oleic (C18:1) acid. Such fatty acid selection was based on their presence in the 
human lung7–9. NTHi375 and RdKW20 viability decreased in the presence of both fatty acids in a dose depend-
ent manner. Arachidonic acid susceptibility was higher for RdKW20 than for NTHi375, leading us to assess 
non-identical concentrations of this fatty acid for both strain backgrounds. As expected, mutant strains lacking 
the vacJ gene displayed higher susceptibility to both arachidonic and oleic acid than their respective WT strains 
(NTHi375, arachidonic acid 25 µM, p < 0.0005; NTHi375, oleic acid 0.8 to 1.6 mM, p < 0.0005; 2 mM, p < 0.05; 
RdKW20, arachidonic acid 3 to 12.5 µM, p < 0.0005; 25 µM, p < 0.05; RdKW20, oleic acid 1.2 to 2 mM, p < 0.005). 
(Fig. 3B,C). Complete or partial restoration was obtained for the ΔvacJ complemented strains, for NTHi375 and 
both free fatty acids, and for RdKW20 and oleic acid (Fig. 3B, left panel; Fig. 3C).
Together, these results showed that NTHi does not grow using free fatty acids as sole carbon source; in turn, 
free fatty acids have a killing effect, further increased by inactivation of the vacJ gene.
VacJ contributes to NTHi interplay with human airway epithelial cells. Given the determinant role 
of NTHi interplay with the human airway epithelium in the progression of infection2,28, we speculate that VacJ 
mediated changes on the bacterial surface may alter such interplay. We next asked whether the lack of VacJ alters 
this host cell-pathogen interaction by infecting NCI-H292 human bronchial epithelial cells with NTHi WT and 
vacJ mutant strains29. NCI-H292 cell invasion of ΔvacJ mutants was lower than that shown by the WT strains 
(for NTHi375 and RdKW20, p < 0.0005) (Fig. 4A). ΔvacJ lower epithelial infection rate was also observed during 
invasion of A549 human type II pneumocytes (for NTHi375, p < 0.05; for RdKW20, p < 0.0005)30,31 (Fig. 4B, left 
and middle panels). Phenotypic restoration could not be achieved with the ΔvacJ complemented strains (Fig. 4). 
Differently, the vacJ gene mutation did not modify epithelial inflammatory response in terms of IL-8 secretion 
by A549 cells upon infection (Fig. 4B, right panel). In summary, VacJ is likely to contribute significantly to H. 
influenzae entry within airway epithelia.
Inactivation of the vacJ gene attenuates H. influenzae virulence in vivo. A genome-wide screen 
for H. influenzae genes required in the lung previously revealed vacJ involvement in pathogenesis18. Following this 
observation, we sought to quantify the impact of vacJ disruption in a NTHi mouse respiratory infection model 
system previously used for NTHi37529,31–34. Mice were infected with NTHi375 WT and vacJ mutant strains, and 
bacterial loads quantified in lung and bronchoalveolar lavage fluid (BALF) samples at 24 and 48 h post-infection 
(hpi). At both post-infection time points, NTHi375ΔvacJ lung and BALF bacterial numbers were lower than 
those recovered for the WT strain (at 24 hpi, lung and BALF samples, p < 0.005 and p < 0.0001 respectively; at 48 
hpi, p < 0.0001) (Fig. 5A).
The use of mice with normal lung function may limit modelling NTHi infection in the context of an emphy-
sematous lung. When tested for NTHi strain 2019, murine lung treatment with elastase resulted in damage 
consistent with COPD/emphysema and impaired clearance of NTHi35. We next speculate that vacJ mutant atten-
uation may be favoured, among others, by lung fatty acids. Lung emphysema, where fatty acids seem to mediate 
airway inflammation6,7, could in turn amplify the attenuation effect of vacJ disruption. To elicit pulmonary dam-
age consistent with emphysema, CD1 mice were treated with porcine pancreatic elastase delivered via nonsurgical 
intratracheal instillation36. Emphysema-related features in elastase-treated mice were confirmed by pulmonary 
function tests and micro-computed tomography (micro-CT) (Fig. S3). Namely, elastase-treated lungs displayed 
higher physiological compliance and lower resistance and elastance than vehicle-treated mice. These results sug-
gest an increment in the lung capacity to expand and a reduction in the resistance to the airflow, as a result of the 
parenchymal degradation induced by the effect of elastase activity. Moreover, micro-CT image scans revealed 
lower X-ray density and swollen lungs in elastase-treated mice, which again correlates with a decrease in lung stiff-
ness and collapsed lung parenchymal structures. All these findings are consistent with those previously reported36. 
Strain
Erythromycin Rifampicin Azithromycin Polymyxin E
aMIC 
(mg/l)
Diameter 
inhibition 
zone (mm)
aMIC 
(mg/l)
Diameter 
inhibition 
zone (mm)
MIC 
(mg/l)
Diameter 
inhibition 
zone (mm) aMIC (mg/l)
NTHi375WT 8 17 0.25 25 2 19 0.094
NTHi375ΔvacJ 3 20 0.094 29 1 21 0.032
RdKW20WT 16 14 0.5 22 4 16 0.047–0.064
RdKW20ΔvacJ 4 18 0.19 23 2 19 0.032
Table 1. Minimal inhibitory concentrations (MIC) of three hydrophobic antibiotics and one antimicrobial 
peptide against NTHi WT and vacJ mutant strains. aMIC (mg/l) of Erythromycin, Rifampicin and Polymyxin E 
obtained by E-test.
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Figure 3. Free fatty acids are not used as carbon and energy source, and reduce NTHi viability in a VacJ 
dependent manner. (A) Growth in MM-FFA is shown as a means of OD600 at the indicated time points 
(mean ± SE). In all strains, glucose allowed exponential growth. Ethanol and arachidonic acid did not render 
bacterial growth, similar to only MM-FFA conditions. Growth curves were performed in quadruplicate, three 
times (n = 12) (B) Arachidonic and (C) oleic acid have a bactericidal effect on NTHi. WT, ΔvacJ and ΔvacJ 
complemented strains grown on chocolate agar were used to generate normalized bacterial suspensions in 
MM-FFA, for further incubation with arachidonic or oleic acid. Results are expressed as percentage of bacterial 
survival (means ± SE), referred to that in the presence of vehicle solution. A dose dependent bactericidal effect 
was observed for both WT strains and fatty acids. Both vacJ mutants were more susceptible to the two fatty acids 
tested than their respective parental strains (NTHi375, arachidonic acid 25 µM, ***p < 0.0005; NTHi375, oleic 
acid 0.8 to 1.6 mM, ***p < 0.0005; 2 mM, *p < 0.05; RdKW20, arachidonic acid 3 to 12.5 µM, ***p < 0.0005; 
25 µM, *p < 0.05; RdKW20, oleic acid 1.2 to 2 mM, **p < 0.005). Complete or partial restoration was observed 
for NTHi375 and both free fatty acids, and for RdKW20 and oleic acid; increased arachidonic acid killing 
was maintained for the RdKW20ΔvacJ complemented strain (arachidonic acid 3 to 12.5 µM, ***p < 0.0005). 
Survival assays were performed in duplicate and at least three times (n ≥ 6). Statistical comparisons of the 
means were performed with two-way ANOVA (Sidak’s multiple comparisons test).
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After 17 days, mice were infected with NTHi375 WT and ΔvacJ strains, and bacterial loads quantified in lung 
samples. Elastase effect on NTHi375 clearance from the lungs was first determined. While bacterial counts 
obtained from lung homogenates were comparable at 24 and 48 hpi, we observed a slight trend to recover higher 
WT bacterial numbers from elastase-treated mice at 12 and 30 hpi (Fig. 5B). As shown above, mock-treated 
animals rendered lower NTHi375ΔvacJ numbers than those recovered for the WT strain at 24 hpi (p < 0.0001), 
30 (p < 0.05) and 48 (p < 0.05) hpi. The counts obtained from elastase-treated mice infected with the mutant 
strain were comparable to those obtained from mock-treated mice at any post-infection time point but, notably, 
elastase-treated animals rendered significantly lower NTHi375ΔvacJ numbers than those recovered for the WT 
strain at 24 (p < 0.001), 30 (p < 0.05) and 48 (p < 0.05) hpi (Fig. 5B). GC-MS analysis of murine lung fatty acid 
methyl ester composition showed the same profile of fatty acyl residues in both normal function and emphysema-
tous lung samples, consisting of saturated myristic, palmitic, stearic and C22:0 (behenic) acids, and unsaturated 
palmitoleic, oleic, C18:2 (linoleic), C20:1, C20:2, C20:3, arachidonic, C22:1 (erucic), C22:4 (docosatetraenoic) 
and C22:6 (docosahexaenoic) acids (Fig. 5C).
Overall, these results support that VacJ is a bacterial factor involved in NTHi pulmonary infection. Under the 
conditions tested, elastase-treated mice showed a subtle impairment of NTHi375 pulmonary clearance; induced 
emphysema did not modify the dynamics of NTHi375ΔvacJ clearance. The panel of saturated and unsaturated 
fatty acids quantified in murine lung samples was comparable for normal function and emphysematous lungs, 
which may contribute to the observed vacJ mutant attenuation in both mouse infection models.
Figure 4. The vacJ gene inactivation decreases NTHi interplay with cultured human airway epithelia. (A) 
NCI-H292 bronchial epithelial cells and (B) A549 type II pneumocytes were used to quantify invasion by 
WT, ΔvacJ and ΔvacJ complemented strains. Inactivation of the vacJ gene triggered significantly lower entry 
into NCI-H292 (for NTHi375 and RdKW20, ***p < 0.0005) and A549 (for NTHi375, p < 0.05; for RdKW20, 
***p < 0.0005) cells than that shown by the WT strains. Same observation was made for ΔvacJ complemented 
strains (NCI-H292 cells: for NTHi375 and RdKW20, ***p < 0.0005; A549 cells: for NTHi375, **p < 0.005; 
for RdKW20, ***p < 0.0005). IL-8 release was comparable in cells infected by NTHi375 WT and vacJ mutant 
strains. Cell invasion assays were carried out in triplicate, at least three times (n ≥ 9). IL-8 levels were quantified 
twice in two independent assays (n = 4). Means ± SD are represented and statistical comparisons of the means 
were performed using two-tail t-test.
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Figure 5. Inactivation of the vacJ gene attenuates H. influenzae virulence. (A) CD1 mice were intranasally 
infected with ~2 × 108 bacteria/mouse of NTHi375 WT (circle) or ΔvacJ (triangle) strains. Mice were 
euthanized at 24 and 48 hpi, and bacterial loads quantified in lungs (left panel, log10 c.f.u./lung) and BALF 
samples (right panel, log10 c.f.u./ml BALF). NTHi375ΔvacJ showed significantly lower loads in lungs and 
BALFs at 24 (*p < 0.005 and **p < 0.0001, respectively) and 48 (**p < 0.0001) hpi than those shown by 
the WT strain. (B) CD1 mice were administered elastase to induce lung emphysema (vehicle solution was 
used as control), and intranasally infected with ~2 × 108 bacteria/mouse of NTHi375 WT (circle) and ΔvacJ 
(triangle) strains. Mice were euthanized at 12, 24, 30 and 48 hpi, and bacterial loads were quantified in lungs. 
White and black symbols refer to bacterial loads in vehicle solution and elastase-treated animals, respectively. 
At 24, 30 and 48 hpi, NTHi375ΔvacJ showed significantly lower loads in lungs than those shown by the WT 
strain (in lungs with normal function, ***p < 0.0001 at 24 hpi, *p < 0.05 at 30 and 48 hpi; in emphysema 
lungs, **p < 0.001 at 24 hpi, *p < 0.05 at 30 and 48 hpi). (C) Determination of total fatty acid composition in 
CD1 mouse lung by GC-MS. A repertoire of fatty acid species was detected and quantified in lung samples 
of CD1 mice (n = 6 per group); same fatty acid profile was observed for lungs with normal function and with 
emphysematous lesions. Means ± SD are shown, statistical comparisons of the means were performed using 
two-tail t-test.
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Discussion
Lipids are important components of the host immunity by organizing membrane signalling complexes and releas-
ing lipid-derived mediators. Changes in the lipid content of the airway epithelium play important roles in cystic 
fibrosis, COPD and asthma, and several lipid molecules are key molecular mediators of disease in these chronic 
respiratory conditions6. In fact, COPD is linked to dysregulation of many metabolic pathways including lipid 
biosynthesis, and reconstruction of a COPD sputum lipid signalling network indicates that arachidonic acid may 
be a critical and early signal distributer upregulated in this disease37. Likewise, pulmonary injury is a trademark 
of acute respiratory distress syndrome associated to oleic acid8,9. Chronic respiratory patients are often persis-
tently infected at their lower airways by NTHi, which may encounter free fatty acids at this host niche. Free fatty 
acid antibacterial properties have been observed for several pathogens including group A streptococci, Neisseria 
gonorrhoeae, mycobacteria, Staphylococcus aureus and H. influenzae10,38–42, but mechanisms counteracting their 
detergent effect have not been detailed. Outer membrane lipid asymmetry plays an essential role in Gram negative 
bacteria barrier function. Its maintenance contributes preserving surface hydrophilicity, further counteracting 
the antibacterial effect of hydrophobic antimicrobials such as fatty acids and numerous conventional antibiotics14. 
Three systems are known to prevent damage resulting from surface exposed phospholipids in Gram negative bac-
teria, including the phospholipase PldA, the palmitoyltransferase PagP and the VacJ-MlaBCDEF phospholipid 
transport system15. In this study, we elucidate the involvement of VacJ in NTHi respiratory infection, as part of the 
only system known to maintain the outer membrane lipid asymmetry found to be present in available genomes of 
this bacterial pathogen, likely to be part of its core genome. Based on the absence of gene homologs, our observa-
tions are likely to be unrelated to a concerted action of VacJNTHi with PldA. Previous evidence indicates that VacJ 
is important for NTHi resistance to serum mediated killing via the classical pathway of complement activation17, 
which may relate to vacJ gene implication in lung pathogenesis18. Here, we link the vacJ gene deficiency with 
increased specific fatty acyl residues in bacterial global fatty acid and phospholipid composition, which may 
contribute to raise bacterial surface hydrophobicity therefore jeopardizing the outcome of NTHi interaction with 
hydrophobic and lipophilic molecules. Of note, similar outcomes were observed upon NTHi vacJ mutant inter-
action not only with hydrophobic antibiotics and synthetic antimicrobial peptides, but also with free fatty acids 
shown to be present in the host lungs, further strengthening the importance of VacJ to maintain NTHi membrane 
stability during its persistent interplay with the host at the human airways.
Fatty acid composition has been previously determined for H. influenzae RdKW20 purified outer membrane 
vesicles and outer membranes, showing abundance of myristic, palmitic, palmitoleic and stearic acid43,44. To our 
knowledge, this is the first report on NTHi total fatty acid composition, further determined in two genetically 
different strains. Our findings support previous observations on major fatty acyl species, and also highlight the 
presence of hydroxymyristic acid. This fatty acid is present in the lipid A molecule24, but absent in total, outer 
membrane vesicle and outer membrane phospholipids of NTHi strains (Fig. 2 and43), therefore narrowing its 
location at the lipid A. Likewise, phospholipid content and species composition in the PE fraction has been pre-
viously determined in NTHi purified outer membrane vesicles and outer membranes43,44. Here, we report NTHi 
phospholipid total content and fatty acyl composition, and show palmitic and stearic acid as shared species in 
both PG and PE. vacJ deletion has been shown to result in the asymmetric expansion of the outer leaflet, sup-
porting the outward budding of the outer membrane to finally form outer membrane vesicles enriched in phos-
pholipids with decreased palmitic and increased myristic acid amounts43. Our results showed that vacJ mutation 
increases total fatty acid content, and vacJ deficient strains showed higher amount of fatty acyl residues, including 
palmitic acid.
Besides VacJ involvement in NTHi membrane integrity and serum resistance17, it also contributes maintaining 
E. coli, Actinobacillus pleuropneumoniae, Haemophilus parasuis and Shigella flexneri membrane integrity15,20,21,23, 
A. pleuropneumoniae and H. parasuis serum resistance and biofilm formation20,23, and H. parasuis virulence in 
vivo20. Moreover, VacJ participates in H. parasuis epithelial adhesion and invasion, and in S. flexneri cell to cell 
spread20,21. In this study, we show that VacJ plays a role in NTHi airway epithelial infection, although a direct role 
for VacJ as a bacterial ligand could not be established. Next to chromosome complementation, the vacJNTHi375 gene 
HA-tagged at the 3′ end, together with its predicted promoter region, was cloned and expressed in E. coli as a het-
erologous host; despite VacJNTHi375-HA expression, confirmed by western blot using a monoclonal mouse anti-HA 
antibody, infection of A549 cells was similar to that shown by control E. coli strain harbouring the empty plasmid 
(Fig. S4). We cannot exclude that defective cell infection could be an indirect effect of vacJ disruption, causing 
outer membrane alterations not only in phospholipids and fatty acids but also in bacterial ligands, which may 
altogether hinder complementation. The reason for this unsuccessful complementation is currently unknown. 
Operon prediction by using the MicrobesOnline tool45 showed that the vacJ gene is unlikely to be part of an 
operon in H. influenzae, therefore excluding possible polar effects. In fact, phenotypic restoration was successful 
when testing bacterial deoxycholate survival and ChoP levels, and partial when testing fatty acid composition and 
fatty acid survival, further supporting the complementation approach employed in this study.
LOS decoration with ChoP is known to relate to NTHi resistance to antimicrobial peptides46. Unexpectedly, 
vacJ gene deficiency was shown to increase NTHi ChoP levels (Fig. 1F and17) but also antimicrobial suscepti-
bility, therefore excluding a VacJ-mediated relationship between bacterial ChoP decoration and resistance to 
PxE. This observation could relate to the lower intensity of the ion peak representing the monophosphorylated 
hexa-acylated lipid A observed in the vacJ mutant strains (Fig. 2B). Likewise, the vacJ gene is known to play a 
role in resistance to oxidative stress in Campylobacter jejuni47. Oxidative stress occurs in the small airways, lung 
parenchyma and alveolar regions in COPD; in asthma, the larger airways are its major site of action. Different to 
C. jejuni, the diameter of NTHi bacterial growth inhibition around H2O2 soaked discs was comparable between 
NTHi ΔvacJ and WT strains (Fig. S1D). Lastly, this work shows VacJ requirement for NTHi pulmonary infection 
in mice, supporting previous observations18, and NTHi375ΔvacJ showed a comparable level of attenuation in 
mice with either normal lung function or lung emphysema. The panel of fatty acids identified and quantified in 
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murine lung samples, next to other soluble and cellular host factors such as antimicrobial peptides or alveolar 
macrophages, may contribute to the observed vacJ mutant decreased numbers, compared to those by the WT 
strain. Similar fatty acid composition for both normal function and emphysematous murine lung samples may 
contribute explaining the comparable vacJ mutant loads in the two tested in vivo models. We acknowledge that 
the emphysema model used in this study generated lung lesions (Fig. S3), but did not modify lung fatty acid 
content, which may relate to potential limitations of the procedure used for emphysema induction over a 17 days 
time window. Further work will be needed to assess the effect of longer elastase treatment on the murine lung 
pathophysiology, also considering fatty acid content.
Analysis of H. influenzae genome sequences revealed the absence of homologs to E. coli PldA, therefore 
excluding a relationship between vacJ disruption and phospholipase-mediated removal of phospholipids at the 
bacterial surface. Similarly, a homolog to E. coli PagP is absent in NTHi, excluding NTHi lipid A hepta-acylation, 
as shown by lipid A determination for WT and vacJ mutant strains. Moreover, vacJ disruption did not modify 
lipid A hexa-acylation, excluding a functional relationship between VacJ and the acyltransferase HtrB. Analysis 
of H. influenzae genome sequences revealed a homolog to the recently characterized E. coli pqiB gene, encoding a 
multi Mammalian Cell Entry (MCE) domain-containing protein displaying a syringe-like architecture periplas-
mic bridge, which may be involved in maintaining cell envelope homeostasis48,49, and will be subject of future 
study. H. influenzae genome sequences also revealed homologs to the E. coli fadL and fadD genes, annotated as 
an exogenous long-chain fatty acid transporter and an acyl-CoA synthase/fatty acid-CoA ligase11,19, but they lack 
the fadE, fadB, fadH and fadA genes, encoding four enzymes involved in fatty acid degradation via β-oxidation50, 
and genes encoding enzymes of the so called β-oxidation complex II51. Conversely, NTHi contains the type II fatty 
acid synthesis (FASII) system, only lacking the fabF gene50,52,53, whose products are substrates for acyltransferases 
catalysing the initial steps in the biosynthesis of phospholipids and lipid A. Those acyltransferases encoding genes 
(plsB and plsC for phospholipids; lpxA, lpxD and msbB for lipid A) are also present in NTHi genomes11,19. Based 
on this gene distribution (for a summary, see Table S3), NTHi may transport long-chain fatty acids to be con-
verted to acyl-CoAs, which could contribute to phospholipid synthesis together with FASII-derived acyl-ACPs, 
but is unlikely to use such fatty acids as carbon and energy source. In fact, when using arachidonic acid as a 
carbon source, NTHi did not grow in a chemically defined medium but, in turn, its survival was reduced in a 
VacJ-dependent manner. Same observations were made for oleic acid, supporting the notion that free fatty acid 
bactericidal effect may be a selective pressure for NTHi to develop counteracting adaptive strategies at the human 
airways during chronic infection. Interestingly, Helicobacter pylori is also susceptible to free fatty acids, lacks 
β-oxidation, and actively exchanges genetic material by natural competence and homologous recombination54–57. 
Despite occupying separate niches at the human body, both pathogens could develop common adaptive strategies 
contributing to colonization linked to chronic disease conditions. Identification and characterization of such 
selective pressures and patho-adaptive counteracting mechanisms will be subject of future studies.
Methods
Bacterial strains, plasmids, media and growth conditions. NTHi strains were grown at 37 °C, 5% 
CO2 on chocolate agar (Biomérieux) or brain-heart infusion (BHI) agar supplemented with 10 µg/ml hemin and 
10 µg/ml nicotinamide adenine dinucleotide (NAD), referred to as sBHI. NTHi liquid cultures were grown in 
sBHI at 37 °C, 5% CO2. Alternatively, NTHi cultures were grown in a defined minimal medium free of fatty acids 
(MM-FFA) (Table S2). MM-FFA consists of MIV solutions S21, S22, S23 and S24 (100:1:1:1)58, 10 µg/ml hemin 
and 10 µg/ml NAD. When necessary, MM-FFA was supplemented with (i) glucose 20 mM, (ii) a free fatty acid, 
(iii) a free fatty acid vehicle solution. Tested free fatty acids were arachidonic and oleic acid, purchased from 
Sigma-Aldrich. Spectinomycin 30 µg/ml (Spec30) and erythromycin 11 µg/ml (Erm11) were used when required. 
Escherichia coli was grown on Luria Bertani (LB) broth or LB agar at 30 °C or 37 °C, supplemented with ampicillin 
100 µg/ml (Amp100), spectinomycin 50 µg/ml (Spec50) or erythromycin 150 µg/ml (Erm150), when necessary.
For vacJ gene disruption, a DNA fragment containing the vacJ gene and its respective adjacent regions 
(1,907 bp) was PCR amplified using genomic DNA from NTHi375 as a template and primers vacJ-F1/931 (5-ATG 
ACTGAAGAAACAACAGTATCAAAA) and vacJ-R1/933 (5′-TTATTTTCTCACTGCAATCGCTTCAATTTC). 
The gene containing PCR product was cloned into pGEM-T easy (Promega), generating pGEMT-vacJ. A Specr  
cassette was PCR amplified from pRSM2832 using gene-specific mutagenic primers vacJ-F2/1354 ( 5′- TT T 
C  AC  A A  AT  TA G G  TA G A  AT A A TC  C C  AT AT T T AT G T A A G G  AT C A  A A  A ATG AT TC C G G G G AT 
CCGTCGACC) and vacJ-R2/1355 (5′-TTAATTGGCGTGGTGTTGTTGCATTATAAATCGGTAGCA 
CAATATAAGTGTGTAGGCTGGAGCTGCTTCG)59. Primers were designed to delete sequences between 
the start codon and the last 7 codons of vacJ. E. coli SW102 cells were prepared for recombineering, 
co-electroporated with pGEMT-vacJ (Ampr) (50 ng) and the vacJ-specific mutagenic cassette (Specr) (200 ng)60. 
Mutagenized clones containing pGEMT-vacJ::spec were selected on LB agar with Amp100, Spec50. This plasmid was used 
as a template to amplify the vacJ::spec disruption cassette with primers vacJ-F1/931 and vacJ-R1/933, which was used 
to transform NTHi375 and RdKW20 using the MIV method58. Transformants were selected on sBHI agar with Spec30, 
to obtain NTHi375ΔvacJ and RdKW20ΔvacJ mutants. Disruptions were confirmed by PCR. Complementation of 
NTHi375ΔvacJ and RdKW20ΔvacJ mutant strains was performed by inserting the vacJ gene into open reading frame 
(ORF) HI0601.1; this ORF contains a frameshift in both RdKW20 and NTHi37531. PCR was used to amplify a 2,342 kb 
fragment from NTHi375 genomic DNA using primers HI0601.1-F1/488 (5′-GAAGTAAGAGATGAAAAGCGAAG) 
and HI0601.1-R1/489 (5′-TTGGTAAAAATGGATGAAGGGGATTAC). This fragment was cloned into SmaI 
digested pUC19, generating pUC19-HI0601.1, which was used as a template for inverse PCR using primers Hi0601.1 
up-XhoI-R/1493 (5′-CCGCTCGAGACAATCAAACCAATAAACCCGAAA) and Hi0601.1down-NcoI-F/1494 
(5′-CATGCCATGGGCAGTATTTTAAAAGCGGATATCA). This PCR product was digested with XhoI and 
NcoI, used as a vector to clone a XhoI and NcoI digested Erm resistance cassette which was PCR amplified using 
pBSLerm61 as a template, and primers ermC-XhoI-F/1517 (5′-CCGCTCGAGGAGCTCGAATTCGGCTTCATGCT) 
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and ermC-NcoI-R/1518 (5′- CATGCCATGGGGTACCGAGCTCGAATTCGGCTTGATCG), to gener-
ate pUC19-HI0601.1-Erm. The vacJ gene with its promoter region was amplified from NTHi375 genomic 
DNA using primers vacJ-XhoI-F/1523 (5′-CCGCTCGAGATGACTGAAGAAACAACAGTATCAAAA) and 
Pr-vacJ-HA-Xhol-R/1524 (5′-CCGCTCGAGTTAAGCGTAGTCTGGGACGTCGT). This PCR product (1,487 bp) 
was XhoI digested and cloned into XhoI-digested pUC19-HI0601.1-Erm, generating pUC19-HI0601.1-Erm-Pr::vacJ. 
This plasmid was used as a template to amplify a 5,015 kb DNA fragment containing HI0601.1 flanked Pr::vacJ, used 
to naturally transform NTHi375ΔvacJ and RdKW20ΔvacJ strains. Complemented strains were selected on sBHI agar 
with Spec30 and Erm11.
Prediction of VacJNTHi characteristics and lipobox motif. Subcellular location of the VacJ lipoprotein 
was predicted using the Cell-Ploc package (http://chou.med.harvard.edu/bioinf/Cell-PLoc/)62. VacJ characteris-
tics were predicted with the PROTEAN program and proteomics tools from the ExPASy website. VacJ lipobox 
sequence was predicted using the DOLOP program63.
Bacterial growth. Strains were grown on chocolate agar for 16 h. Bacterial suspensions collected in PBS were 
normalized to OD600 = 1, diluted to OD600 = 0.05 in sBHI, and 200 µl aliquots were transferred to individual wells 
in 96-well microtiter plates (Falcon). Plates were incubated with agitation at 37 °C for 12 h in a Multiskan instru-
ment (Thermo Scientific), and OD636 was monitored every 15 min. Each growth curve was corrected to its blank 
values (sBHI). Alternatively, a bacterial suspension recovered with 1 ml MM-FFA from a freshly grown chocolate 
agar plate was adjusted to OD600 = 1. Arachidonic acid stock solution (100 mM) was prepared and diluted to the 
requiredworking concentrations in ethanol. Then, 160 μl of (i) MM-FFA, (ii) MM-FFA with arachidonic acid 
25 μM, (iii) MM-FFA with fatty acid vehicle solution, i.e. ethanol volumes identical to those used for arachidonic 
acid 25 μM, (iv) MM-FFA with glucose 20 mM, were transferred to individual wells in 96-well microtiter plates 
(Sarstedt). Next, 40 μl of the previously prepared bacterial suspensions were added to each well. Plates were incu-
bated in a SpectraMAX 340 microplate reader at 37 °C, and OD600 was recorded every 30 min for 12 h.
Lipid A purification and analysis. Lipid A was extracted and processed by using an ammonium hydroxide/
isobutyric acid method and subjected to negative-ion matrix-assisted laser desorption ionization time-of-flight 
(MALDI-TOF) mass spectrometry25. Freshly grown bacteria on chocolate agar were scraped from the plates, 
resuspended in 400 µl isobutyric acid–1 M ammonium hydroxide (5:3 [v/v]) and incubated in a screw-cap test 
tube at 100 °C for 2 h, with occasional vortexing. Samples were cooled in ice water and centrifuged (2,000 × g for 
15 min). The supernatant was transferred to a new tube, diluted with an equal volume of water, and lyophilized. 
The sample was then washed twice with 400 µl methanol and centrifuged (2,000 × g for 15 min). The insoluble 
lipid A was solubilized in 100 to 200 µl chloroform-methanol-water (3:1.5:0.25 [v/v/v]). Analyses were performed 
on a Bruker autoflex® speed TOF/TOF mass spectrometer (Bruker Daltonics Inc.) in negative reflective mode 
with delayed extraction. The ion-accelerating voltage was set at 20 kV. To analyse the samples, 1 to 3 µl of lipid 
A suspension (1 mg/ml) were desalted with a few grains of ion-exchange resin (Dowex 50W-X8; H) in a 1.5 ml 
microcentrifuge tube. A 1 µl aliquot of the suspension (50 to 100 µl) was deposited on the target and covered with 
the same amount of dihydroxybenzoic acid matrix (Sigma-Aldrich) dissolved in 0.1 M citric acid. Different ratios 
between the samples and dihydroxybenzoic acid were used when necessary. Alternatively, lipid A was mixed 
with 5-chloro-2-mercapto-benzothiazole (Sigma-Aldrich) at 20 mg/ml in chloroform-methanol (1:1 [v/v]) at a 
ratio of 1:5. Each spectrum was an average of 300 shots. A peptide calibration standard (Bruker Daltonics) was 
used to calibrate the MALDI-TOF. Further calibration for lipid A analysis was performed externally using lipid 
A extracted from E. coli strain MG1655. Interpretation of the negative-ion spectra was based on earlier studies 
showing that ions with masses higher than 1,000 gave signals proportional to the corresponding lipid A species 
present in the preparation64.
NTHi lipid extraction and phospholipid separation by TLC. Bacterial total lipids were extracted using 
the Bligh and Dyer Method65. Briefly, 10 ml of bacterial suspensions normalized in distilled water (OD600 = 1) 
were prepared by collecting biomass from NTHi strains grown on chocolate agar. Bacterial suspensions were 
pelleted, resuspended in 0.2 ml distilled water and 0.75 ml chloroform:methanol (1:2 [v/v]), incubated for 5 min 
with- and for 15 min without shaking, followed by centrifugation (15,000 g, 20 min). Supernatants were trans-
ferred to a new tube with 0.5 ml chloroform:water (1:1 [v/v]), agitated for 5–15 min, and centrifuged (15,000 g, 
20 min) to separate organic and aqueous phases. Next, 0.4 ml of the organic phase (bottom) were transferred to 
a clean tube. All steps were performed at room temperature (RT). Chloroform was evaporated from samples 
(SpeedVac) and dried extracts were stored at −20 °C prior TLC. Dried lipids were dissolved in 60 μl chloroform 
and spotted in duplicate onto a TLC plate (silica gel 60, Merck). TLC plates were placed in a solvent saturated tank 
(chloroform:methanol:acetic acid, 13:5:2 [v/v/v]) for phospholipid separation. After separation, dried TLC plates 
were placed in an iodine chamber for band visualization, scraped or, alternatively, developed by charring with 
sulfuric acid 15% in ethanol at 180 °C.
Determination fatty acid composition. Fatty acid composition and quantity were determined by 
GC-MS of the corresponding fatty acid methyl esters (FAMEs). NTHi FAMES were prepared as it follows: tripli-
cates of chocolate agar grown bacteria were normalized in 1 ml PBS to OD600 = 3 and pelleted to obtain ∼40 mg 
bacterial biomass. Both these samples and scraped phospholipids from TLC separation (see section above), were 
treated with NaOH 15% (1 ml) in methanol:water (1:1, v/v) for 30 min at 100 °C. Saponified material was meth-
ylated with methanol (2 ml) in 50% (v/v) HCl 6 N for 10 min at 80 °C. In this step, 20 μl of the internal standard 
C17:0 (1 mg/ml) were added. NTHi FAMEs were extracted with 1.25 ml hexane:methyl tertbutyl ether (1:1, v/v), 
and added to a new tube (900 μl) containing 4 ml NaOH 3% in distilled water as washing step. ∼300 μl of remain-
ing the organic phase (top) were carefully transferred to a GC vial and capped (Technical note #101, MIDI). 
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For murine lung FAMEs preparation, lung homogenates (see below) were stored at −80 °C. Five hundred μl of 
each homogenate were mixed with 750 μl HCl-methanol (3 N), 150 μl toluene and 20 μl of the GC-MS internal 
standard (C17:0, 1 mg/ml), and incubated at 90 °C for 1 h. Next, 500 µl NaCl 0.9% and 500 µl hexane were added, 
mixed vigorously, and centrifuged at 2,000 r.p.m for 5 min at RT. Supernatants (~300 µl) were transferred to a new 
tube, dried overnight in a chemical cabinet at RT, and the pellet obtained was resuspended in 100 µl hexane for 
further GC-MS analysis.
GC-MS analyses of bacterial and murine lung FAMEs were performed using a 7890A GC device coupled to 
a 5975C Inert XL MSD mass selective detector (Agilent Technologies, Santa Clara, USA). A volume of 1 μl was 
injected on an Agilent J&W DB-WAX column (diameter, 0.25 mm; film thickness, 0.25 μm; length, 30 m) with a 
1 ml/min helium flow. Injection parameters were as it follows: split mode injection (1:10) and injector tempera-
ture 250 °C. The temperature gradient was 1 min at 50 °C; 25 °C/min up to 200 °C; 3 °C/min up to 230 °C and then 
18 min at 230 °C, and the solvent delay was 5 min. The source was set to 230 °C and 70 eV, scanning at 20 scans/
min, from 40 to 500 m/z. FAMEs were identified by comparing their mass spectra with those of the NIST library 
and by comparison of the retention times with a FAME standard mix (Sigma-Aldrich).
Bacterial hydrophobicity. Duplicates of chocolate agar grown bacteria were normalized in 2.5 ml PBS to 
OD600 = 0.5 (A1) in capped tubes. Next, 0.5 ml xylene (PanReac AppliChem) were added per tube, the mixture was 
incubated at 44 °C for 10 min, vigorously vortexed for 1 min, incubated under the same conditions for 1 h, and the 
aqueous phase OD600 (A2) was measured. Results are expressed as percentage of bacterial surface hydrophobicity 
([(A1 − A2)/A1] × 100). Strong hydrophobic and hydrophilic bacteria get values >50% and <20%, respectively66.
Antimicrobial susceptibility testing. Susceptibility to ampicillin, amoxicillin-clavulanic acid, cefuro-
xime, cefepime, cefotaxime, ceftriaxone, imipenem, meropenem, chloramphenicol, tetracycline, ciprofloxa-
cin, cotrimoxazole and azithromycin was determined by microdilution according to the criteria of the Clinical 
Laboratory Standards Institute (CLSI)67. Susceptibility to the hydrophobic antibiotics erythromycin, azithromy-
cin and rifampicin was also determined by E-test (Biomérieux) and/or disc diffusion (Becton Dickinson). For 
PxE, bacterial susceptibility was determined by E-test (Biomérieux).
Detergent susceptibility testing. PBS normalized bacterial suspensions (OD600 = 1) were prepared by 
using NTHi strains freshly grown on chocolate agar. Then, 100 µl of normalized suspensions were transferred 
to individual wells in 96-well microtiter plates (Sarstedt), to be incubated with 100 µl sodium deoxycholate 
(Alfa-Aesar) for 20 min at RT in static conditions. A deoxycholate stock solution (43.25 mg/ml) was prepared 
in dH2O and diluted to the required working concentrations in PBS (0.5; 0.75; 1; 1.25; 1.5 mg/ml). Bacterial 
suspensions were next used to (i) measure OD405; (ii) ten-fold dilution in PBS and plating on sBHI agar for c.f.u. 
counting (represented as log10 c.f.u./ml); (iii) five µl of serial culture dilutions (10−1) from each well were spotted 
on sBHI agar for visualization.
TEM. PBS normalized NTHi suspensions (OD600 = 1) were prepared by using NTHi strains freshly grown on 
chocolate agar. Then, 100 µl of such suspensions were incubated with none or with 100 µl sodium deoxycholate 
0.5 mg/ml for 20 min at RT in static conditions. Bacteria were next applied to Formvar-coated grids, air dried, 
negatively stained with 1% phosphotungstic acid in distilled water for 10 s, and examined with a JEM-1011 trans-
mission electron microscope (JEOL) operating at 80 kV and equipped with an Orius SC1000 charge-coupled 
device (CCD) camera (Gatan).
Free fatty acids susceptibility testing. MM-FFA normalized bacterial suspensions (OD600 = 0.1) were 
prepared by using NTHi strains grown on chocolate agar. Oleic and arachidonic acid stock solutions (100 mM) 
were prepared and diluted to the required working concentrations in ethanol. For arachidonic acid, tested con-
centrations ranged from 3 to 75 μM; for oleic acid, tested concentrations ranged from 0.8 to 2 mM. MM-FFA with 
fatty acid (160 µl) was transferred to individual wells in 96-well microtiter plates (Sarstedt); 40 µl of the previously 
prepared bacterial suspensions were added to each well, and incubated for 20 h at 37 °C with 5% CO2 in static con-
ditions. Vehicle solution, consisting of an ethanol volume equivalent to that used for the highest fatty acid con-
centration tested, and only MM-FFA controls were performed in parallel. After incubation, bacteria were serially 
diluted in PBS and plated on sBHI agar. Results are expressed as percentage of bacterial survival ([c.f.u.ml−1fatty acid × 
100]/c.f.u.ml−1 vehicle).
ChoP quantification. Three to four colonies of NTHi grown on chocolate agar were inoculated into 20 ml 
sBHI, grown for 11 h, diluted in 40 ml sBHI to OD600 = 0.05, grown to OD600 = 0.6, serially diluted, plated on sBHI 
agar for c.f.u. determination, and used to generate stocks stored at −80 °C in sBHI with 20% glycerol as single 
use aliquots. An aliquot containing ~107 c.f.u. was thawed and incubated for 1 h at 37 °C with TEPC-15, a mouse 
monoclonal antibody specific for ChoP (Sigma-Aldrich) diluted 1:25 in PBS-0.05% Tween 20. Samples were 
washed twice with PBS-0.05% Tween 20, and incubated with a fluorescein isothiocyanate (FITC)-conjugated rab-
bit anti-mouse (Serotec) diluted 1:300 in PBS-0.05% Tween 20 for 30 min at 4 °C under dark conditions. Bacteria 
were washed with PBS-0.05% Tween 20, fixed in 3% paraformaldehyde (PFA) for 2–3 min at RT, and analysed 
on a FACSCalibur flow cytometer (BD Biosciences) using forward and side scatter parameters to gate on at least 
25,000 bacteria. Results are expressed as a relative percentage fluorescence index (RFI), to measure both the pro-
portion of fluorescent bacteria positive for ChoP and the intensity of fluorescence34.
RNA extraction and RT-qPCR analysis. NTHi strains were grown on chocolate agar. Bacteria (2 to 
5 colonies) were inoculated into 20 ml sBHI, grown for 11 h, diluted into 40 ml fresh sBHI to OD600 = 0.05, 
and grown to OD600 = 0.6. Bacterial total RNA was isolated using TRIzol reagent (Invitrogen), according to 
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manufacturer’s instructions. Total RNA quality was evaluated using RNA 6000 Nano LabChips (Agilent 2100 
Bioanalyzer). All samples had intact 16 S and 23 S ribosomal RNA bands. Reverse transcription was performed 
using 1 µg RNA by PrimerScript RT Reagent kit (Takara). To monitor lic1A gene expression, PCR amplification 
was performed by using SYBR Premix Ex Taq II (Tli RNaseH Plus) (Takara) and primers Lic1ART-Fw/1098 
(5′-TCCATTCCTTTTTCCTCCATTG) and Lic1ART-Rv/1099 (5′-AAGTAGAACATTTTGATTGGTCATTCC). 
16S ribosomal RNA was amplified with primers 16S-Fw/1074 (5′-GGCGTTGATGACCGTGAAAC) and 
16S-Rv/1075 (5′-GCCAGTAATAATCGCCCTCTTCTAG). Fluorescence data were analysed with AriaMx 
Real-Time PCR System (Agilent Technologies). Relative mRNAs quantities were calculated using the comparative 
threshold cycle (Ct) method and normalized using 16S ribosomal RNA (16SrRNA) as an endogenous control.
Cell culture and bacterial infection. A549 human alveolar basal epithelial cells (ATCC CCL-185) were 
maintained and seeded as described68. NCI-H292 mucoepidermoid pulmonary human carcinoma epithelial cells 
(ATCC CRL-1848) were maintained and seeded as described29. Invasion assays were performed and processed 
as described29,30,32,33,68. For infection, PBS-normalized bacterial suspensions (OD600 = 1) were prepared by using 
NTHi strains grown on chocolate agar. A multiplicity of infection (MOI) of ~100:1 was used. Cells were infected 
for 2 h in 1 ml EBSS (Earle’s Balanced Salt Solution, Gibco), washed 3 times with PBS, incubated for 1 h with RPMI 
1640 medium containing 10% FCS, Hepes 10 mM and gentamicin 200 μg/ml. Cells were then washed 3 times with 
PBS, lysed with 300 μl PBS-saponin 0.025% for 10 min at RT, and serial dilutions were plated on sBHI agar. Results 
are expressed as c.f.u./well.
Secretion of IL-8. Bacteria grown on chocolate agar were collected with PBS, suspensions were normalized 
to OD600 = 1, and used for 2 h infections. A549 cells were washed 3 times with PBS, and incubated for 6 h in RPMI 
1640 medium containing 10% FCS, Hepes 10 mM and gentamicin 100 µg/ml. Supernatants were collected from 
the wells, cell debris removed by centrifugation and samples frozen at −80 °C. IL-8 levels in the supernatants were 
measured by ELISA (Abnova KA0115) with sensitivity <2 pg/ml. Results are expressed as IL-8 pg/ml.
NTHi mouse lung infection. A CD1 mouse model of NTHi lung infection was used29,32–34. CD1 female 
mice (18–20 g) aged 4 to 5 weeks purchased from Charles River Laboratories (France) were housed under 
pathogen-free conditions at the Institute of Agrobiotechnology facilities (registration number ES/31-2016-
000002-CR-SU-US). Animal handling and procedures were in accordance with the current European (Directive 
86/609/EEC) and National (Real Decreto 53/2013) legislations, following the FELASA and ARRIVE guidelines, 
and with the approval of the Universidad Pública de Navarra (UPNa) Animal Experimentation Committee 
(Comité de Ética, Experimentación Animal y Bioseguridad) and the local Government authorization. NTHi375 
WT and mutant strains were used for lung infection. When necessary, mice were randomly divided into three 
groups (n ≤ 8): (i) control mice with normal lung function; (ii) mice with lung emphysema; (iii) elastase vehicle 
solution. Emphysema was induced by intratracheal administration of porcine pancreatic elastase (EPC, Elastin 
Products Company). To do so, 10 mg containing 1,350 elastase units (U) were resuspended in 10 ml physiological 
serum to generate a stock solution (1 mg/ml, i.e. 135 U/ml). To induce emphysema, one 90 μl dose containing 6 
elastase U/mouse was administered 17 days before infection. Infecting bacteria were previously grown on choc-
olate agar. For NTHi intranasal infection, 20 μl of a bacterial suspension containing ~2 × 108 c.f.u. was placed at 
the entrance of the nostrils until complete inhalation by each mouse, previously anesthetized (ketamine-xylazine, 
3:1). When indicated, mice were euthanized and lungs aseptically removed. The left lung was individually 
weighed in sterile bags (Stomacher80, Seward Medical) and homogenized 1:10 (w/v) in PBS. Each homogenate 
was serially 10-fold diluted in PBS and plated in triplicate on sBHI agar to determine the number of viable bacte-
ria. Results are shown as log10 c.f.u./lung. When required, remaining homogenate material was stored at −80 °C 
to determine lung fatty acid composition (see section above). In parallel, BALF samples were obtained in animals 
with normal lung function by perfusion and collection of 0.7 ml of PBS, with the help of a sterile 20 G (1.1-mm 
diameter) Vialon intravenous catheter (Becton-Dickinson) inserted into the trachea. Each recovered BALF frac-
tion was serially 10-fold diluted and plated on sBHI agar. Results are shown as log10 c.f.u./ml BALF.
Animal preparation and pulmonary function tests (PFT). Pulmonary function tests were performed 
in all animals before micro-CT acquisition. To this end, animals were first anesthetized with an intraperito-
neal injection of 90 mg/kg ketamine (Imalgene®, Merial, France) and 10 mg/kg xylazine (Rompun®, Bayer AG, 
Germany). Anesthetized animals were intratracheally cannulated and connected to a Flexivent rodent ventilator 
(Scireq, Montreal, Canada) set at a rate of 200 breaths/min and a tidal volume of 10 ml/kg. Animals were kept 
breathing isoflurane at 2% concentration until completely relaxed. Lung resistance (R, measured in cmH2O.s/
mL), compliance (C, measured in mL/cmH2O) and elastance (E, measured in cmH2O.s/mL) parameters were 
measured by using a single-frequency-forced oscillation, fitting the measured data to a single compartment 
model of the lung. All measurements were repeated at least five times.
Breath-hold gated micro-CT imaging and image analysis. Lung 3D tomographic images were 
acquired using X-ray micro-CT (Micro-CAT II, Siemens PreClinical Solutions, Knoxville, Tennessee) with the 
following parameters: 80 kVp X-ray source voltage, 500 μA current and 450 ms exposure time per projection. 
Seven hundred micro-CT projections were acquired during 650 ms iso-pressure breath holds at 12 cm H2O. 
Normal breathing was induced during two complete respiratory cycles between breath holds. A total lung capac-
ity perturbation was performed every 20 breath holds to prevent atelectasis. The tomographic three-dimensional 
images obtained had a total of 640 slices with isotropic 46 μm voxel size and a resolution of 1024 × 1024 pixels 
per slice. Micro-CT images were automatically reconstructed by using the Cobra software (Exxim Computing 
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Corporation, CA, USA) and 3D lung images were processed by using the Amira 3D Software for preclinical anal-
ysis (Thermo Scientific, MA, USA).
Statistical analysis. In all cases, p < 0.05 value was considered statistically significant. Analyses were per-
formed using Prism software, version 7 for Mac (GraphPad Software) statistical package.
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